phenobarbital will lessen the level or impact of eltrombopag by influencing hepatic enzyme CYP2C9/ten metabolism. Use Warning/Monitor.Steer clear of; coadministration with CYP3A inducers may end in lessened plasma concentrations of elvitegravir and/or perhaps a concomitantly administered protease inhibitor and cause lack of therapeutic impact and a